The global blood screening market is expected to reach a value of
USD 3.9 billion by 2024, based on a new report by Grand View Research, Inc. The
growth of the market is attributed to the increasing screening of donor and
continuous technological advancements by the market players. Demand for blood
screening tests are increasing continuously due to increasing donation, rising
awareness about transfusion-transmitted diseases, and technological
developments in the industry.
Thorough screening is necessary for all donated
blood to ensure that recipients receive the safest products. As of 2015, such
testing consists of screening for red cell antibodies, and the infectious
diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human
T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum
(syphilis). Result of all these assays must be negative for blood donation.
Technological developments in the market increase
the sensitivity and efficiency of the tests. For instance, in 2016, the U.S.
FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to
screen donated blood. Furthermore, the U.S. FDA approved next-generation
sequencing (NGS) technology in 2013. The technology is cheaper and faster than
previous DNA analysis methods.
Full research report on blood
screening market analysis:
http://www.grandviewresearch.com/industry-analysis/blood-screening-market
http://www.grandviewresearch.com/industry-analysis/blood-screening-market
Further Key Findings from the Study
Suggest:
·
Nucleic acid amplification test or nucleic acid
test (NAT) is expected to be the fastest growing segment during the forecast
period. It comprises transcription mediated amplification (TMA) tests and
polymerase chain reaction. Increasing demand of NAT over ELISA test due to high
sensitivity and specificity for viral nucleic acid is contributing to the
fastest growth during the forecast period.
·
In 2015, reagent dominated the product segment.
Introduction of new assays for the detection of various diseases is expected to
enable the segment to gain the maximum share of market in the coming years. For
instance, in January 2015 the FDA approved Roche’s blood screening assay COBAS
TaqScreen MPX Test for the detection and identification of HCV, HIV, and
HBV.
·
In 2015, regionally North America dominated with
a revenue share of more than 40%. Government initiatives, presence of major
players, and more patient affordability are the major factors that contributed
toward its dominance.
·
In August 2016, the FDA recommended the testing
of all the donated blood in the U.S. and its territories for Zika virus in
order to prevent transmission of this virus through the blood supply.
·
Asia Pacific is expected to be the fastest
growing region due to increasing investment of industry players, government
initiatives, and rising awareness about transmission of diseases during its
transfusion.
·
The Red Cross in Japan entered into a contract
with Grifols for nucleic acid testing (NAT) for a blood donation camp in Japan
in 2014. This agreement is anticipated to propel the NAT market during the
forecast period. However, low donation as compared to requirement and high cost
of kits and instruments are likely to restrain the growth in low-income
countries during the forecast period.
View more reports of this category by
Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the blood screening market by technology, product and region:
Blood Screening Market Technology Outlook (Market Revenue in USD Million, 2013 - 2024)
·
Nucleic Acid Amplification Test (NAT)
·
ELISA
·
Chemiluminescence Immunoassay (CLIA) and Enzyme
Immunoassay (EIA)
·
Next-Generation Sequencing (NGS)
·
Western Blotting
Blood Screening Market Product Outlook (Market Revenue in USD
Million, 2013 - 2024)
·
Reagent
·
Instrument
Blood Screening Market Regional Outlook (Market Revenue in USD
Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
·
Middle East and Africa
o
South Africa
For press release of this report - http://www.grandviewresearch.com/press-release/global-blood-screening-market
No comments:
Post a Comment